Clinical trial registry record

Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Heat and Air Pollution

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated June 5, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07606859
Last registry update
June 5, 2026
Status
Recruiting
Phase
Phase not reported
Sponsor
University of Cyprus
Enrollment
102
Countries
Cyprus, Spain
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · PREVENTION · NONE
Evidence population
Human clinical study registration
Participants
102
Population
ALL · 65 Years
Duration
2026-05-01 to 2027-07-31
Intervention
Heat intervention; Heat and air pollution mitigation intervention
Comparator
Control group
Outcomes measured
Percentage dipping in night-time systolic blood pressure (SBP) — Percentage dipping (Dipping %=([Mean Daytime SBP-Mean…; Pittsburgh Sleep Quality Index (PSQI) — The PSQI will be assessed at baseline, middle (after 1 month), and at end of ob…; Sleep-wake pattern — Daily measurements - for the whole duration of follow-up (2 months); Sleep-Wake self-reported evaluation — The sleep-wake self-reported evaluation will be assessed at baseline, middle (aft…; Hamilton Anxiety Rating Scale — The Hamilton Anxiety Rating Scale will be assessed at baseline, middle (after 1 month),…; Daily heart rate — Daily measurements - for the whole duration of follow-up (2 months); Heart Rate — Heart Rate will be assessed at baseline, middle (after 1 month), and at end of observation period (after 2…; Heart Rate Variability — The heart rate variability will be assessed at baseline, middle (after 1 month), and at end of…; The personal ambient temperature profile of all participants — Daily measurements - for the whole duration of follow-up…; Wet-bulb globe temperature (WGBT) — Daily measurements - for the whole duration of follow-up (2 months); Humidity — Daily measurements - for the whole duration of follow-up (2 months); Indoor concentration levels of PM2.5 and PM10 at residence — Daily measurements - for the whole duration of follow-up (…; Number of daily steps — Daily measurements - for the whole duration of follow-up (2 months); Serum C-reactive Protein (CRP) levels — Serum levels of CRP will be assessed at baseline, middle (after 1 month), and a…; Serum Urea Levels — Serum levels of urea will be assessed at baseline, middle (after 1 month), and at end of observatio…; Serum Creatinine Levels — Serum levels of creatinine will be assessed at baseline, middle (after 1 month), and at end o…; Serum Sodium levels — Serum levels of sodium will be assessed at baseline, middle (after 1 month), and at end of observ…; Serum Potassium levels — Serum levels of potassium will be assessed at baseline, middle (after 1 month), and at end of…; Serum Osmolality — Serum osmolality will be assessed at baseline, middle (after 1 month), and at end of observation per…; Urine Creatinine Levels — Urine levels of creatinine will be assessed at baseline, middle (after 1 month), and at end o…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Air pollution and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.

air pollution aging
Read the original source →Export JSON